Testicular Dysfunction in 47,XXY Boys: When It All Begins. A Semilongitudinal Study.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
18 09 2023
Historique:
received: 20 12 2022
medline: 19 9 2023
pubmed: 13 4 2023
entrez: 12 4 2023
Statut: ppublish

Résumé

Klinefelter syndrome is the most common chromosomal disorder in males and the most common cause of hypergonadotropic hypogonadism. We describe the natural history of testicular dysfunction in patients with Klinefelter syndrome through the integration of clinical, hormonal, and quantitative ultrasound data in a life-course perspective. Prospective semilongitudinal study. We included 155 subjects with 47,XXY karyotype (age range: 7 months-55 years) naïve to testosterone replacement therapy. Subjects were divided according to pubertal stage and age group (transition age and adults). Serial clinical, hormonal, and testicular ultrasound (US) assessments were performed. Testicular development progresses until Tanner stage 4, with subsequent regression, whereas Sertoli and germ cell impairment is not hormonally detected before Tanner stages 3-4, as reflected by normal inhibin B values until stage 4 and the fall in the inhibin B/follicle-stimulating hormone ratio thereafter. The testosterone/luteinizing hormone ratio peaks during Tanner stages 2-3 and declines from Tanner stage 4 onward, preceding the development of overt hypogonadism. US echotexture progressively worsens until transition age, reflecting ongoing gonadal compromise, whereas quantitative US echotexture measures and the presence of both hypoechoic lesions and microlithiasis independently and significantly predict a lower circulating testosterone level. The findings from this large prospective study contribute to our understanding of the natural history of testicular dysfunction in Klinefelter syndrome, underlining the importance of quantitative testicular US in infancy and childhood, as well as during pubertal development and transition age, for the optimal care of Klinefelter syndrome patients.

Identifiants

pubmed: 37043499
pii: 7116194
doi: 10.1210/clinem/dgad205
pmc: PMC10505551
doi:

Substances chimiques

Testosterone 3XMK78S47O
Follicle Stimulating Hormone 9002-68-0
Inhibins 57285-09-3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2486-2499

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.

Références

Mol Cytogenet. 2021 Jan 6;14(1):1
pubmed: 33407708
Andrology. 2020 Sep;8(5):1051-1063
pubmed: 32445591
Am J Hum Genet. 2021 Oct 7;108(10):1924-1945
pubmed: 34626582
J Pediatr. 2016 Mar;170:260-5.e1-2
pubmed: 26746120
J Endocrinol Invest. 2010 Dec;33(11):839-50
pubmed: 21293172
J Pediatr (Rio J). 2012 Jul;88(4):323-7
pubmed: 22915094
Eur J Hum Genet. 2008 Feb;16(2):163-70
pubmed: 18000523
Basic Clin Pharmacol Toxicol. 2008 Feb;102(2):155-61
pubmed: 18226069
Invest Radiol. 2009 Jul;44(7):405-11
pubmed: 19465863
Front Cell Dev Biol. 2022 Feb 03;9:801597
pubmed: 35186953
Prenat Diagn. 1997 Apr;17(4):363-8
pubmed: 9160389
J Clin Endocrinol Metab. 2022 May 17;107(6):1560-1568
pubmed: 35225342
J Clin Endocrinol Metab. 2022 Jan 1;107(1):e236-e245
pubmed: 34407199
Andrology. 2015 Sep;3(5):868-75
pubmed: 26235799
J Clin Endocrinol Metab. 2011 Apr;96(4):E746-53
pubmed: 21307139
Pediatr Radiol. 2018 Nov;48(12):1771-1778
pubmed: 29980860
Int J Urol. 2008 Jun;15(6):529-33
pubmed: 18430152
Horm Res. 2008;69(6):317-26
pubmed: 18504390
Pediatr Res. 2006 Jun;59(6):854-9
pubmed: 16641204
Hum Reprod. 2019 Aug 1;34(8):1389-1403
pubmed: 31532522
J Endocrinol Invest. 2023 Jan;46(1):181-188
pubmed: 36001286
J Pathol. 2003 Mar;199(3):378-86
pubmed: 12579540
Clin Pediatr (Phila). 2001 Dec;40(12):639-51
pubmed: 11771918
Hum Reprod. 2012 Feb;27(2):323-30
pubmed: 22166807
Eur Radiol. 2002 Jan;12(1):19-34
pubmed: 11868071
Int J Endocrinol. 2012;2012:324835
pubmed: 22291701
J Gynecol Obstet Hum Reprod. 2021 Nov;50(9):102177
pubmed: 34087451
J Clin Endocrinol Metab. 2004 May;89(5):2263-70
pubmed: 15126551
Metabolism. 2018 Sep;86:135-144
pubmed: 29382506
Andrology. 2014 Mar;2(2):275-81
pubmed: 24574169
J Endocrinol Invest. 2021 Jul;44(7):1465-1474
pubmed: 33095904
J Endocrinol Invest. 2021 Jan;44(1):127-138
pubmed: 32378142
J Clin Endocrinol Metab. 2003 Feb;88(2):622-6
pubmed: 12574191
Fertil Steril. 2012 Aug;98(2):266-73
pubmed: 22846647
Arch Dis Child. 1970 Feb;45(239):13-23
pubmed: 5440182
Clin Endocrinol (Oxf). 2018 May;88(5):711-718
pubmed: 29446828
Clin Endocrinol (Oxf). 2007 Dec;67(6):863-70
pubmed: 17645574
J Clin Res Pediatr Endocrinol. 2017 Oct 12;10(2):100-107
pubmed: 29022558
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
Lancet. 1974 Jul 20;2(7873):171
pubmed: 4135537
J Clin Endocrinol Metab. 2004 Apr;89(4):1864-8
pubmed: 15070957
J Endocrinol Invest. 2017 Feb;40(2):123-134
pubmed: 27644703
Reproduction. 2013 Mar 01;145(3):237-44
pubmed: 23315688
Clin Genet. 1980 Jul;18(1):1-5
pubmed: 7418248
Abdom Radiol (NY). 2016 Aug;41(8):1596-603
pubmed: 27029388
Andrology. 2021 Jan;9(1):145-167
pubmed: 32959490
South Med J. 1986 Sep;79(9):1089-93
pubmed: 3529433
Acta Paediatr. 2011 Jun;100(6):793-806
pubmed: 21362037
J Clin Endocrinol Metab. 1988 Jan;66(1):62-7
pubmed: 2891722
Hum Reprod. 2018 Jun 1;33(6):1009-1022
pubmed: 29684126
J Endocrinol Invest. 2017 Jul;40(7):705-712
pubmed: 28258556
Horm Res. 2005;64(1):39-45
pubmed: 16088206
Clin Endocrinol (Oxf). 2022 Mar;96(3):363-370
pubmed: 34523156
Arch Dis Child. 1976 Mar;51(3):170-9
pubmed: 952550
Andrology. 2020 Sep;8(5):1005-1020
pubmed: 32353207
Arch Dis Child. 1982 Jan;57(1):6-12
pubmed: 7065696
Eur J Endocrinol. 2001 Nov;145(5):561-71
pubmed: 11720872
J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72
pubmed: 10523012
Hum Reprod. 2016 May;31(5):947-57
pubmed: 26936886
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4864-4873
pubmed: 32071206
J Clin Endocrinol Metab. 2003 Feb;88(2):888-91
pubmed: 12574229
Eur J Pediatr. 2021 Oct;180(10):3201-3207
pubmed: 33934233
Hum Reprod. 2012 Apr;27(4):998-1004
pubmed: 22313866
Pediatr Pathol. 1985;3(2-4):245-59
pubmed: 2937030
Eur J Endocrinol. 2007 Sep;157(3):345-50
pubmed: 17766718

Auteurs

Carlotta Pozza (C)

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Franz Sesti (F)

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Marta Tenuta (M)

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Matteo Spaziani (M)

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Chiara Tarantino (C)

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Francesco Carlomagno (F)

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Marianna Minnetti (M)

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Riccardo Pofi (R)

Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism and NIHR Oxford Biomedical Research Centre, Churchill Hospital, University of Oxford, Oxford OX37LE, UK.

Roberto Paparella (R)

Department of Pediatrics, Sapienza University of Rome, 00161 Rome, Italy.

Andrea Lenzi (A)

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Antonio Radicioni (A)

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Andrea M Isidori (AM)

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Luigi Tarani (L)

Department of Pediatrics, Sapienza University of Rome, 00161 Rome, Italy.

Daniele Gianfrilli (D)

Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH